Clinical Trial Update: Transformation Potential of E2 Exposed Breast Cancer Susceptibility Gene Mutation Heterozygous Epithelial Breast Cells

View source ↗

Summary

This clinical trial update examines whether exposure to estradiol (E2) can promote transformation in epithelial cells heterozygous for BRCA1 or BRCA2 mutations,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hereditary Breast and Ovarian Cancer Syndrome

Snippet

Sponsor: Hadassah Medical Organization | Conditions: BRCA1 Gene Mutation, BRCA2 Gene Mutation | Status: UNKNOWN